Clinical Trials Browser

Has results × Triple Negative Breast Neoplasms × serabelisib × Clear all

NCT03193853 2023-08-07

TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer

Phase 2 Completed

12 enrolled 11 charts

Triple Negative Breast Neoplasms